csirt@kutim:~/threat-intel/cve/CVE-2026-40315

Katalog CVE

CVSS 9.8 · Critical EPSS 0,40%

Kerentanan Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') pada praisonai. Skor CVSS 3.1 9.8 (Critical) menurut NVD.

Deskripsi (NVD)

PraisonAI is a multi-agent teams system. Prior to 4.5.133, there is an SQL identifier injection vulnerability in SQLiteConversationStore where the table_prefix configuration value is directly concatenated into SQL queries via f-strings without any validation or sanitization. Since SQL identifiers cannot be safely parameterized, an attacker who controls the table_prefix value (e.g., through from_yaml or from_dict configuration input) can inject arbitrary SQL fragments that alter query structure. This enables unauthorized data access, such as reading internal SQLite tables like sqlite_master, and manipulation of query results through techniques like UNION-based injection. The vulnerability propagates from configuration input in config.py, through factory.py, to the SQL query construction in sqlite.py. Exploitation requires the ability to influence configuration input, and successful exploitation leads to internal schema disclosure and full query result tampering. This issue has been fixed in version 4.5.133.

Rincian

Terbit di NVD
14 April 2026
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
9.8 (Critical), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-89: Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection')
EPSS (30 hari)
0,40% peluang dieksploitasi; lebih tinggi dari 32,8% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
praison praisonai Semua versi sebelum 4.5.133

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.